Carboplatin, vinblastine and mitomycin-C in the treatment of non-small cell bronchogenic carcinoma

J Chemother. 1992 Jun;4(3):196-9. doi: 10.1080/1120009x.1992.11739164.

Abstract

Thirty patients with advanced non-small cell lung carcinoma were treated with carboplatin, vinblastine and mitomycin-C. Objective tumor regression was noted in 6 patients. Toxicity of this combination was moderate.

Publication types

  • Clinical Trial

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carboplatin / administration & dosage
  • Carcinoma, Bronchogenic / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Squamous Cell / drug therapy*
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Mitomycin / administration & dosage
  • Vinblastine / administration & dosage

Substances

  • Mitomycin
  • Vinblastine
  • Carboplatin